In addition to symptomatic treatment SLOTXO There is also favipiravir. that the Department of Medicine has allowed it to be used to treat Covid-19 patients as well.
What is favipiravir?
Favipiravir is active against a wide range of RNA viruses, including the influenza virus, foot-and-mouth disease virus, and yellow fever virus. There are also ongoing studies with a variety of human pathogenic viruses.
In February 2021, favipiravir was approved in China for the treatment of influenza in adults. and allow it to be used in clinical studies with COVID-19 patients, and South Korea is considering urgent approval for drug registration. for the treatment of COVID-19
Favipiravir is currently in clinical trials to evaluate both efficacy and safety. and it is one of the drugs of hope for the treatment of COVID-1.
Favipiravir Registered to treat influenza It is a broad-acting antiviral drug. It can therefore be used for other viral infections such as chikungunya and COVID-19.
The use of favipiravir in patients with COVID-19
Doctors use favipiravir on COVID-19 patients received in a hospital The Department of Disease Control states that it is used for people who have started to have symptoms of the disease. It is not recommended for people who have not had symptoms. or used to prevent disease
In case of confirmed infection asymptomatic and there are no co-morbidities, there will be no specific drug treatment.
In case of confirmed infection and have mild symptoms or without symptoms but with co-morbidities/risk factors from the beginning will not give medicine as symptomatic treatment But a new approach when there are few symptoms or without symptoms but with risk factors like this ripple People with obesity die more. Experts have gathered information. therefore specifying to treat by administering antiviral drugs at the discretion of the treating physician
In case of confirmed infection with few symptoms and risks and mild pneumonia In addition to favipiravir, Steroids in severe cases can reduce severe symptoms requiring ventilator support.
Patients stand standing, pneumonia, blood oxygen concentration at room temperature less than 96%, or severe pneumonia. will still use the same approach
